Canadian Sec - Free Realtime Quote CAD
Bright Minds Biosciences Inc. (DRUG.CN)
46.03
+1.85
+(4.19%)
As of 11:57:32 AM EDT. Market Open.
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-2,522.49
-1,850.19
-7,024.27
-13,587.12
-7,319.30
Financing Cash Flow
51,973.43
810.57
2,189.69
5,196.19
26,055.60
End Cash Position
56,212.59
5,720.09
6,747.99
11,627.91
19,760.02
Issuance of Capital Stock
48,628.96
900
1,217.50
4,034.88
27,744.83
Repayment of Debt
-91.56
-89.73
-86.11
-7.16
0
Free Cash Flow
-2,522.49
-1,850.19
-7,024.27
-13,587.12
-7,319.30
9/30/2021 - 2/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6XC.F Soleno Therapeutics, Inc.
64.85
+1.25%
688428.SS InnoCare Pharma Limited
20.56
+0.54%
25I.SG ImmuPharma PLC
0.0265
-10.17%
BSFAF BSF Enterprise Plc
0.0584
0.00%
22Z.SG Zealand Pharma A/S
56.18
-6.30%
BT3.BE Lineage Cell Therapeutics Inc
0.4060
+5.73%
328.SG MeiraGTx Holdings PLC
4.7600
-0.83%
688068.SS Beijing Hotgen Biotech Co., Ltd.
109.40
-0.18%
XUPB.F Genfit S.A.
3.7800
-0.53%
SCP.F Scancell Holdings plc
0.0950
0.00%